More research is needed to find out the long-term effects of using colistin on humans
Click here to read more
FDA has helped to create antibiotic-intensive livestock system of US
Click here to read more
Many countries now have national AMR action plans, but implementation remains vastly different
Click here to read more
Educating children on antimicrobial use instils responsible habits and attitudes early on, shaping the behaviour of future patients and caregivers
Click here to read more
The three-zone biosecurity initiative by FAO was originally launched in 2013 to contain avian flu outbreaks
Click here to read more
Adopting a whole-of-society and multi-sectoral approach is essential to address AMR effectively
Click here to read more
We need policies to reward R&D, bring products to market and ensure equitable access and prudent use
Click here to read more
A hub-and-spoke model of AMR surveillance has been initiated in almost all districts
Click here to read more
At present, drug development is only profitable if combination of prices and sales volumes is sufficiently high
Click here to read more
New antibiotic research & development model required to ensure people most in need get access to right drugs
Click here to read more
There are many advantages to using a global functions framework rather than just the narrow public goods framework
Click here to read more
Today, one in five bacterial infections in Europe is caused by a pathogen that is resistant to antibiotics
Click here to read more
There should be a movement to treat AMR as a national issue, pass policies and fund innovation. Such efforts would then have a cascading effect and allow funding to pour in from private investors
Click here to read more
The risk of AMR posed by the release of antibiotic manufacturing waste can be prevented
Click here to read more
Crisis with AMR obliges dairy sector to look beyond maximising cattle productivity and focus on both milk quantity, quality
Click here to read more
Problem underpinned by complex drivers and behaviours; multisectoral and multidimensional efforts required
Click here to read more
Being in the pharmaceutical field, the mantle of responsibility falls upon us to forge ahead in the relentless pursuit of solutions to the daunting challenge of AMR
Click here to read more
CSE-DTE speak to Virander S Chauhan and Nitin Yadav, co-founders of Biotide Solutions LLP, about the global AMR scenario
Click here to read more